0001624794-23-000020.txt : 20230418
0001624794-23-000020.hdr.sgml : 20230418
20230418163553
ACCESSION NUMBER: 0001624794-23-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230417
FILED AS OF DATE: 20230418
DATE AS OF CHANGE: 20230418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Armes Joseph B
CENTRAL INDEX KEY: 0001413614
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37454
FILM NUMBER: 23827283
MAIL ADDRESS:
STREET 1: 5420 LYNDON B, JOHNSON FREEWAY
STREET 2: SUITE 500
CITY: DALLAS
STATE: TX
ZIP: 75240
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CSW INDUSTRIALS, INC.
CENTRAL INDEX KEY: 0001624794
STANDARD INDUSTRIAL CLASSIFICATION: ADHESIVES & SEALANTS [2891]
IRS NUMBER: 472266942
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5420 LYNDON B. JOHNSON FREEWAY
STREET 2: SUITE 500
CITY: DALLAS
STATE: TX
ZIP: 75240
BUSINESS PHONE: (214) 884-3777
MAIL ADDRESS:
STREET 1: 5420 LYNDON B. JOHNSON FREEWAY
STREET 2: SUITE 500
CITY: DALLAS
STATE: TX
ZIP: 75240
FORMER COMPANY:
FORMER CONFORMED NAME: CSWC Newco Corp.
DATE OF NAME CHANGE: 20141110
4
1
wf-form4_168185014021968.xml
FORM 4
X0407
4
2023-04-17
0
0001624794
CSW INDUSTRIALS, INC.
CSWI
0001413614
Armes Joseph B
5420 LYNDON B JOHNSON FWY
STE. 500
DALLAS
TX
75240-1007
1
1
0
0
Chairman, President & CEO
1
Common Stock
2023-04-17
4
S
0
14
138.28
D
67570
D
Common Stock
2023-04-17
4
S
0
229
139.79
D
67341
D
Common Stock
2023-04-17
4
S
0
521
140.82
D
66820
D
Common Stock
2023-04-17
4
S
0
236
141.61
D
66584
D
Common Stock
1500
I
JBA Family Partners, L.P.
Restricted Stock Units
Common Stock
19685.0
19685
D
Performance Rights
Common Stock
27559.0
27559
D
Performance Rights
Common Stock
13735.0
13735
D
The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.28 to $138.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.32 to $140.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.36 to $141.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.36 to $141.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle ending on each of March 31, 2024 and 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
/s/Luke E. Alverson, Attorney in Fact
2023-04-18